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ABSTRACT 
 
In this report, we describe a simple synthesis of gluconoamidinylsulfones as a new class of potential 
inhibitors toward glycan processing enzymes. Gluconoamidinylsulfones have a glucose-based 
sulfonyl amidine skeleton, thus would form a distorted half-chair conformation with positive charge, 
which is analogous to transition state in the enzymatic process. A chemoselective coupling reaction 
between thioamide and sulfonyl azide enabled one-step synthesis of the iminosugar derivatives 
from commercially available D-gluconothiolactam in a protection-free manner. The phenyl-
substituted gluconoamidinylsulfone displayed high inhibitory ability toward - and -glucosidases 
with Ki values of 13.9 and 8.2 M, respectively, resulting that gluconoamidinylsulfones would be 
expected to entry in a new class of promising potential inhibitors toward various glycan-processing 
enzymes. 
Short Research Article 
Keywords: Inhibitor; glycosidase; 
sulfonyl azide; gluconoamidinylsulfone.
 
1. INTRODUCTION 
 
Iminosugars have been developed as small
molecule inhibitors for various types of glycan 
processing enzymes [1,2]. These inhibitors are 
crucial for detailed understanding of glycobiology 
as well as for development of new promising 
medicines prescribed in the treatmen
diabetes, Gaucher’s disease, influenza infection, 
HIV, hepatitis, cancer, etc., involving glycoside
bond cleavage pathway [3]. Chemical structures 
of glycosidase-inhibiting natural products afford 
valuable inspirations to design their synthetic 
analogues. Miglitol [4,5] and miglustat [6,7] are 
representative therapeutic iminosugars for 
diabetes and type-1 Gaucher’s disease (GD1), 
respectively, derivatized from a natural 
glucosidase inhibitor, 1-deoxynojirimycin [8] 
(Fig. 1a). On the other hand, rationally designed 
iminosugars based on the mechanism of the 
enzymatic hydrolysis reaction have also been 
synthesized as candidates of lead compounds 
for glycosidase inhibition [3,9]. A mechanism
based general strategy is transition
analogue of the enzymatic process. Shape and 
charge are the key points to mimic the transition 
state, that is, a partially planar structure in 
distorted half-chair conformations and 
delocalized positive charge around the anomeric 
center of the glycosyl oxocarbenium 
intermediates (Fig. 1b), the species 
considered close to the transition state of the 
 
Fig. 1. Chemical structures of (a) 1
oxocarbenium intermediate, (c) a gluconoamidine (protonation form under physiological 
conditions), and (d) a gluconoamidinylsulfone (protonation form under physiological 
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hydrolysis process, are important common 
factors for designing potent glycosidase 
inhibitors. One of the successful inhibitors 
designed in this way is gluconoamidines (Fig. 1c) 
that have both a partially flattened geometry and 
positive charge at a basic amidine center under 
physiological conditions, which exhibited 
remarkable inhibition abilities toward 
glycosidases [10-12]. 
 
We recently reported a chemoselectiv
between thioamides and sulfonyl azides to yield 
sulfonyl amidines without side reaction even 
under the coexistence of hydroxy, amino, and 
carboxy groups [13,14] (Scheme 1a). The 
reaction proceeds in various solvents without any 
activation additives. In the previous report [13], a 
six-membered cyclic thioamide, 2-
with methyl and phenyl sulfonyl azides showed 
good reactivity in EtOH or H2O (Scheme 1b). 
Inspired by the structural similarity of 2
thiopiperidone with iminosugars, we 
that commercially available D-gluconothiolactam 
would afford sulfonyl amidine derivatives of D
gluconolactam, namely gluconoamidinylsulfones 
(Fig. 1d), by the coupling reaction with sulfonyl 
azides. Here we report simple synthesis of 
gluconoamidinylsulfones 1 and 2 as a new class 
of potential inhibitors for glycosidase. In addition, 
conventional inhibitory assay of these 
compounds toward - and -glucosidases is also 
described. 
 
-deoxynojirimycin, miglitol, and miglustat, (b) a glycosyl 
conditions) 
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Scheme 1. Chemoselective coupling reaction between (a) thioamides and sulfonyl azides in 
general and (b) 2
 
2. MATERIALS AND METHODS
 
2.1 General 
 
1
H and 
13
C NMR spectra were obtained at 400 
and 100 MHz, respectively, on a JEOL ECX
400P spectrometer. ESI-HRMS analyses were 
conducted on a Thermo LTQ Orbitrap XL ETD 
mass spectrometer. 
 
2.2 Materials 
 
D-Gluconothiolactam 3 is commercially available 
from FCH Group (order number: FCH3937573) 
but takes long time around 8 weeks to arrive, 
thus 3 was synthesized by simple procedures 
shown in Scheme 3. D-Gluconolactam 
phenyl sulfonyl azide [14], and mesyl azide
were prepared according to literature 
procedures. Other materials including dehydrate
grade solvents were all commercially available 
(Wako Pure Chemical Industries, Ltd. and Tokyo 
Chemical Industry Co., Ltd.). 
 
2.3 Synthetic Procedures 
 
2.3.1 N-Sulfonylphenyl D-gluconoamidine 1
 
A mixture of 3 (6.1 mg, 0.03 mmol) and phenyl 
sulfonyl azide (30.1 mg, 0.15 mmol) in distilled 
water (0.5 mL) was vigorously stirred at 50°C for 
24 h. After removal of the solvent, the residue 
was purified by silica gel PTLC (preparative thin 
layer chromatography) with a development 
solvent of CHCl3:MeOH = 2:1 to afford 
colorless solid (6.4 mg, 68%). 
1
H NMR (400 
MHz, D2O, TSP): 7.96 (dd, J = 1.4, 7.6 Hz, 2 
H), 7.74 (tt, J = 1.4, 7.6 Hz, 1 H), 7.64 (t, 
Hz, 2 H), 4.14 (d, J = 9.6 Hz, 1 H), 3.96 (dd, 
3.2, 11.6 Hz, 1 H), 3.73 (t [dd], J = 9.6 Hz, 1 H), 
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-thiopiperidone and phenyl sulfonyl azide 
 
-
5 [15,16], 
 [17] 
-
 
1 as a 
J = 7.6 
J = 
3.64 (t [dd], J = 9.6 Hz, 1 H), 3.60 (dd, 
11.6 Hz, 1 H), 3.50 ppm (ddd, J 
Hz, 1 H). 
13
C NMR (100 MHz, D
169.0, 142.5, 136.5, 132.3, 128.9, 75.6, 74.0, 
70.3, 63.8, 61.8 ppm. ESI-HRMS (
MH
+
, C12H17N2O6S: 317.0807; found 317.0801, 
and calcd for MNa+, C12H16N2O6SNa: 339.0627; 
found 339.0620. 
 
2.3.2 N-Sulfonylmethyl D-gluconoamidine 2
 
A mixture of 3 (5.8 mg, 0.03 mmol
azide (17.8 mg, 0.15 mmol) in distilled water (1 
mL) was vigorously stirred at room temperature 
for 72 h. After removal of the solvent, the residue 
was purified by silica gel PTLC with a 
development solvent of CHCl3:MeOH = 2:1 to 
give 2 as a colorless solid (6.2 mg, 82%). 
NMR (400 MHz, D2O, TSP):  4.18 (d, 
Hz, 1 H), 3.96 (dd, J = 2.8, 12.0 Hz, 1 H), 3.80 (t 
[dd], J = 9.6 Hz, 1 H), 3.72 (t [dd], 
H), 3.69 (dd, J = 6.4, 12.0 Hz, 1 H), 3.53 (ddd, 
= 2.8, 6.4, 9.2 Hz, 1 H), 3.13 ppm (s, 3 H). 
NMR (100 MHz, D2O, TSP):  168.8, 75.6, 73.8, 
70.2, 63.6, 61.8, 43.9 ppm. ESI
calcd for MH+, C7H15N2O6S: 255.0651; found 
255.0644, and calcd for MNa
+
, C
277.0470; found 277.0463. 
 
2.3.3 2,3,4,6-Tetra-O-(tert-butyldimethylsilyl)
D-gluconolactam 6 
 
A mixture of D-gluconolactam 5 
mmol), tert-butyldimethylsilyl chloride (TBDMSCl; 
1.97 g, 12.8 mmol) and imidazole (1.76 g, 25.7 
mmol) in anhydrous DMF (2 mL) was vigorously 
stirred at 0°C for 30 min then at room 
temperature for 3 days under an argon 
atmosphere. The mixture was poured into ice 
water (10 mL) and extracted with Et
mL). The combined organic phase was washed 
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J = 7.2, 
= 3.2, 7.2, 9.6 
2O, TSP):  
m/z) calcd for 
 
) and mesyl 
1
H 
J = 9.2 
J = 9.6 Hz, 1 
J 
13C 
-HRMS (m/z) 
7H14N2O6SNa: 
-
(189 mg, 1.1 
2O (3x15 
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with saturated NaCl aqueous solution (5x15 mL) 
and then dried over MgSO4. After removal of the 
solvent, the residue was chromatographed (SiO2; 
eluent, hexane:EtOAc = 5:1) to give 6 (352 mg, 
51%) as a colorless solid. 1H NMR (400 MHz, 
CDCl3, TMS):  5.74 (brs, 1 H), 3.96–3.98 (m, 1 
H), 3.86 (dd, J = 1.6, 3.2 Hz, 1 H), 3.80 (dd, J = 
3.2, 10.0 Hz, 1 H), 3.69–3.75 (m, 1 H), 3.60 (dt, J 
= 1.6, 6.4 Hz, 1 H) 3.55 (dd, J = 7.6, 10.0 Hz, 1 
H), 0.892 (s, 9 H), 0.887 (s, 18 H), 0.86 (s, 9 H), 
0.14 (s, 3 H), 0.13 (s, 3 H), 0.11 (s, 6 H), 0.10 (s, 
3 H), 0.07 (s, 3 H), 0.06 ppm (s, 6 H). ESI-HRMS 
(m/z) calcd for MNa
+
, C30H67NO5Si4Na: 
656.3994; found 656.3982. 
 
2.3.4 2,3,4,6-Tetra-O-(tert-butyldimethylsilyl)-
D-gluconothiolactam 7 
 
A mixture of 6 (352 mg, 0.55 mmol) and 
Lawesson’s reagent (167 mg, 0.41 mmol) in 
toluene (2.5 mL) was refluxed for 3 h. After 
removal of the solvent in vacuo, the residue was 
chromatographed (SiO2; eluent, hexane:EtOAc = 
20:1) to give 7 (288 mg, 80%) as a pale yellow 
solid. 
1
H NMR (400 MHz, CDCl3, TMS):  7.90 
(brs, 1 H), 4.50–4.52 (m, 1 H), 3.86–3.90 (m, 2 
H), 3.74–3,80 (m, 1 H), 3.56−3.63 (m, 2 H), 0.90 
(s, 9 H), 0.889 (s, 9 H), 0.886 (s, 9 H), 0.86 (s, 9 
H), 0.18 (s, 3 H), 0.17 (s, 3 H), 0.16 (s, 3 H), 0.12 
(s, 3 H), 0.10 (s, 3 H), 0.09 (s, 3 H), 0.07 (s, 3 H), 
0.01 ppm (s, 3 H). ESI-HRMS (m/z) calcd for 
MH
+
, C30H68NO4SSi4: 650.3946; found 650.3954. 
 
2.3.5 D-Gluconothionolactam 3 
 
AcCl (221 mg, 2.82 mmol) was added slowly and 
dropwisely to a MeOH (6 mL) solution of 7 (153 
mg, 0.235 mmol) at room temperature and the 
reaction mixture was stirred for 6 h at that 
temperature. After removal of the solvent, the 
residue was dissolved in water. The aqueous 
solution was then flushed through a reverse-
phase chromatograph cartridge (Mega BE 18C) 
to give 3 (46 mg, 98%) as a colorless solid. 
1
H 
NMR (400 MHz, D2O, TSP):  3.98 (d, J = 9.6 
Hz, 1 H), 3.86 (dd, J = 2.8, 12.4 Hz, 1 H), 3.83 (t 
[dd], J = 9.6 Hz, 1 H), 3.76 (dd, J = 4.0, 12.4 Hz, 
1 H), 3.65 (t [dd], J = 9.6 Hz, 1 H), 3.42 ppm 
(ddd, J = 2.8, 4.0, 9.6 Hz, 1 H). 
13
C NMR (100 
MHz, D2O, TSP):  206.2, 77.4, 75.6, 70.2, 64.8, 
62.5 ppm. ESI-MS (m/z) calcd for MH
+
, 
C6H12NO4S: 194; found 194. 
 
2.4 Enzymatic Assays 
 
Glucosidase inhibitory assays were carried out 
for 1, 2, and 1-deoxynojirimycin by means of a 
conventional spectrometric method [18]                       
at 37°C using 0.01 M KH2PO4/K2HPO4 buffer 
solution (pH 6.8). As a substrate, 4-nitrophenyl-
-glucopyranoside (-NGP) toward -
glucosidase from yeast Saccharomyces 
cereviceae or 4-nitrophenyl--glucopyranoside 
(-NGP) toward β−glucosidase from sweet 
almonds was selected. In advance to the assays, 
stock solutions of enzymes (2U/mL for -
glucosidase and 6U/mL for -glucosidase), 
substrates (1 mM), and inhibitors (1, 5, 10, 25, 
50, 100, and 1000 M) were prepared by diluting 
with the buffer. Mixed solutions of an appropriate 
amount of -NGP or -NGP substrate with 
various concentrations of each inhibitor solution 
were poured in cells of a 96-well microplate. 
Addition of the enzyme solution to the cells 
immediately progressed the enzymatic reaction, 
affording 4-nitrophenolate anion as a                   
cleavage product that can be monitored at 405 
nm of absorbance by a microplate reader 
(FilterMax F5TM). The absorption data were 
simultaneously collected from 1 to 25 min at 2 
min intervals. In these assays, the final 
concentrations of the substrates were 16.7, 33.3, 
50.0, 66.7, and 83.3 M for -glucosidase 
whereas 30.0, 60.0, 90.0, 120, and 150 M in 
absence or presence of the inhibitors. The 
inhibition constants (Ki) were determined by 
using the slopes of Lineweaver−Burk plots and 
double reciprocal analysis. All experiments were 
conducted in duplicate and obtained data were 
averaged. 
 
3. RESULTS AND DISCUSSION 
 
One-step syntheses of gluconoamidinylsulfones 
1 and 2 were performed by simply mixing of 
commercially available D-gluconothiolactam 3 
with phenyl sulfonyl azide or mesyl azide in water 
(Scheme 2). The reaction mixture was vigorously 
stirred for an appropriate reaction time, affording 
gluconoamidinylsulfones 1 and 2 in 68% and 
86% isolated yields, respectively. These 
compounds were characterized by means of 
1
H 
NMR, 
13
C NMR and ESI-HRMS (electrospray 
ionization high resolution mass spectrometry) 
(Fig. 2). Because regio- and stereoselective 
sugar derivatization generally tends to be a 
complicated multistep synthesis involving 
protection and deprotection steps, it is 
noteworthy that, by using this coupling reaction, 
one-step synthesis in a protection-free manner 
generated a new class of potential inhibitors 
directly.  
Scheme 2. Protection-free, one
 
Fig. 2. 
1
H NMR (A and B: 400 MHz in D
TSP), and ESI-HRMS (E and F: under the data collection time of 1 min after mass calibration 
with polyethylene glycol) spectra of gluconoamidinylsulfones 1 (left side) and 2
 
D-gluconothiolactam 3 is commercially available, 
however, it seems to take about two months to 
arrive. Thus, we prepared 3 separately according 
to literature procedures [10,15,16] with minor 
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-step synthesis of gluconoamidinylsulfones 1 and 2 by the 
coupling reaction 
 
2O with TSP), 
13
C NMR (C and D: 100 MHz in D
modification (Scheme 3). Gluconolactam 
initially synthesized from a readily purchasable 
in a manner similar to those reported [15,16]. 
Unfortunately, direct thioamidation of 
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2O with 
 
5 was 
4 
5 by 
Lawesson’s reagent (LR) was failed to produce 
3. Silylation of 5 with TBDMSCl followed by 
thioamidation with LR was a successful route, 
affording a thiolactam derivative 7
the silyl-protection with AcCl in MeOH generated 
D-gluconothiolactam 3 quantitatively.
 
Next, enzymatic assay was performed for 
gluconoamidinylsulfones toward glucosidases by 
means of a conventional spectroscopic 
methodology with 4-nitrophenyl 
glucopyranoside as a substrate. Table 1 shows 
the inhibitory ability of gluconoamidinylsulfones 
and 2 against -glucosidase from yeast 
cereviceae (E.C. 3.2.1.20) and 
from almonds (E.C. 3.2.1.21). In advance, trial 
assays were conducted by using 1
deoxynojirimycin, which displayed the inhibition 
constant Ki of 24.5 μM for -glucosidase and 
28.1 μM for -glucosidase (Table 1). Although 
multiple Ki values have been reported for 1
deoxynojirimycin toward the glucosidases under 
the different measurement setup [1,8], the 
 
Scheme 3. Synthesis of D
Reagents and reaction conditions: (a) TBDMSCl, imidazole, dry DMF, rt, 3 days, 51%, (b) Lawesson’s reagent, 
toluene, reflux, 3 h, 80%, (c) AcCl, MeOH, rt, 6 h, 98%.
 
Table 1. Inhibition constants of 1 and 2 toward 
 
Inhibitors Ki for 
 
 
13.9
 
 
>1000
 
1-deoxynojirimycin 
 
24.5
a: -glucosidase from yeast S. cereviceae, b: 
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. Removal of 
 
- or -
1 
S. 
-glucosidase 
-
-
obtained Ki values in this study fall within the 
range of these values, indicating that our assay 
condition and analysis procedure would be 
appropriate and reliable. Phenyl
exhibited strong inhibition against both 
glucosidases with Ki of 13.9 a
respectively, being more high inhibitory ability 
than that of 1-deoxynojirimycin. On the other 
hand, methyl-substitution showed weak inhibition 
against both - and -glucosidases.
 
Glycosyl hydrases have several subsites in t
binding pocket such as glycon and aglycon 
binding sites [18]. The aglycon subsites are 
usually made up of several hydrophobic residues 
such as phenylalanine, tyrosine, and tryptophan 
surrounding a ligand saccharide. Therefore, as 
an old trick, connecting a hydrophobic glycon 
analogue to aglycon mimics like iminosugars has 
been used for glycol-modification [19,20]. The 
strong glucosidase inhibition of the 
gluconoamidinylsulfone 1 seemly caused by the 
aglycon phenyl-group that might fit with the
 
-gluconothiolactam 
 
- and -glucosidases
-glucosidasa (M) Ki for -glucosidas
 
 
8.2 
 
 
764 
 
 
28.1 
-glucosidase from sweet almonds.
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-substituted 1 
- and -
nd 8.2 μM, 
 
heir 
 
 
b (M) 
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aglycon subsite of - and -glucosidases. From 
the analysis of amino acid sequence and three-
dimensional structure, there are several 
phenylalanine residues around aglycon subsite 
of glucosidases [21]. In addition to the 
geometrically and electrostatically well-fitting of 
the gluconoamidine skeleton at the glycon 
subusite, hydrophobic and - interactions at the 
aglycon site might affect effectively, at least in 
part, to the inhibition activity of phenyl-substituted 
1, while the methyl group in 2 exhibited weak 
interaction with the subsite. Although only two 
gluconoamidinylsulfones and glucosidases were 
used in this report, the results indicate that 
further study may reveal the potential of this 
skeleton as a new class of inhibitors toward 
various glycan-processing enzymes such as 
mannosidases, galactosidases, and 
transferases, by taking advantage of the simple 
synthetic approach. 
 
4. CONCLUSION 
 
The chemoselective coupling reaction of D-
gluconothiolactam and sulfonyl azides 
successfully generated gluconoamidinylsulfones 
in a simple synthetic manner. The phenyl-
substituted gluconoamidinylsulfone showed high 
inhibitory ability toward α- and β-glucosidases so 
that gluconoamidinylsulfones would be expected 
to entry in a new class of promising potential 
inhibitors toward various glycosidases. Making 
the best use of the synthetic advantage, 
expansion of the compound library of 
gluconoamidinylsulfones and the following 
enzyme assays toward wide variety of glycosyl 
hydrases and transferases are currently in 
progress.  
 
ACKNOWLEDGEMENTS 
 
This work was supported by a grants-in-aid of 
The Fugaku Trust for Medicinal Research, and 
JSPS Kakenhi Grant Numbers JP25350976 and 
JP17K08363 to J.C. This work was also 
supported by JSPS Core-to-Core Program, B. 
Asia-Africa Science Platforms. 
 
COMPETING INTERESTS 
 
Authors have declared that no competing 
interests exist. 
 
REFERENCES 
 
1. Stütz AE, editor. Iminosugars as 
glycosidase inhibitors: Nojirimycin and 
beyond. Weinheim: WILEY-VCH; 1999. 
2. Gloster TM, Vocadlo DJ. Developing 
inhibitors of glycan processing enzymes as 
tools for enabling glycobiology. Nat Chem 
Biol. 2012;8(8):683-94. 
3. Gloster TM, Davis GJ. Glycosidase 
inhibition: Assessing mimicry of the 
transition state. Org Biomol Chem. 2010; 
8(2):305-20. 
4. Scott LJ, Spencer CM. Miglitol: A review of 
its therapeutic potential in type 2 diabetes 
mellitus. Drugs. 2000;59(3):521-49. 
5. Sugimoto S, Nakajina H, Kosaka K, Hosoi 
H. Review: Miglitol has potential as a 
therapeutic drug against obesity. Nutr 
Metab. 2015;12:51. 
6. Smid BE, Hollak CEM. A systematic review 
on effectiveness and safety of eliglustat for 
type 1 gacher disease. Expert Opin 
Orphan Drugs. 2014;2(5):523-9. 
7. Lyseng-Williamson KA. Miglustat: A review 
of its use in niemann-pick disease type C. 
Drugs. 2014;74(1):61-74. 
8. Hughes AB, Rudge AJ. Deoxynojirimycin: 
synthesis and biological activity. Nat Prod 
Rep. 1994;11(2):135-62. 
9. Ganem B, Papandreou G. Mimicking the 
glucosidase transition state: Shape/Charge 
considerations. J Am Chem Soc. 1991; 
113(23):8984-5. 
10. Tong MK, Papandreou G, Ganem B. 
Potent, broad-spectrum inhibition of 
glycosyntheses by an amidine derivative of 
d-glucose. J Am Chem Soc. 1990; 
112(16):6137-9. 
11. Papandreou G, Tong MK, Ganem B. 
Amidine, amidrazone, and amidoxime 
derivatives of monosaccharide 
aldonolactams: Synthesis and evaluation 
as glycosidase inhibitors. J Am Chem Soc. 
1993;115(25):11682-90. 
12. Heck MP, Vincent SP, Murray BW, 
Bellamy F, Wong CH, Mioskowski C. 
Cyclic amidine sugars as transition-state 
analogue inhibitors of glycosidases: Potent 
competitive inhibitors of mannosidases. J 
Am Chem Soc. 2004;126(7):1971-9. 
13. Aswad M, Chiba J, Tomohiro T, Hatanaka 
Y. Coupling reaction of thioamides with 
sulfonyl azides: An efficient catalyst-free 
click-type ligation under mild conditions. 
Chem Commun. 2013;49(87):10242-4. 
14. Aswad M, Chiba J, Tomohiro T, Hatanaka 
Y. Evaluation of dipole moment and 
electrophilicity on the nature of click-type 
coupling reaction between thioamide and 
sulfonyl azide. Tetrahedron Lett. 2016; 
57(12):1313-6. 
 
 
 
 
Aswad et al.; IRJPAC, 14(2): 1-8, 2017; Article no.IRJPAC.34259 
 
 
 
8 
 
15. Li T, Guo L, Zhang Y, Wang J, Zhang Z, Li 
J, et al. Structure-activity relationships in a 
sseries of C2-substituted gluco-configured 
tetrahydroimidazopyridines as -
glucosidase inhibitors. Bioorg Med Chem. 
2011;19(7):2136-44. 
16. Overkleeft HS, Wiltenburg JV, Pandit UK. 
A facile transformation of sugar lactones to 
azasugars. Tetrahedron. 1994;50(14): 
4215-24. 
17. Danheiser RL, Miller RF, Brisbois RG, 
Park SZ. An improved method for the 
synthesis of -diazo ketones. J Org Chem. 
1990;55(6):1959-64. 
18. Davies GJ, Wilson KS, Henrissat B. 
Nomenclature for sugar-binding subsites in 
glycosyl hydrolases. Biochem J. 1997; 
321(2):557-9. 
19. Yuasa H, Saotome C, Kanie O. Design 
syntheses of inhibitors of glycoenzymes. 
Trends Glycosci Glycotechnol. 2002; 
14(78):231-51. 
20. Hakamata W, Kurihara M, Okuda H, Nishio 
T, Oku T. Design and screening strategies 
for -glucosidase inhibitors based on 
enzymological information. Curr Top Med 
Chem. 2009;9(1):3-12. 
21. Tagami T, Yamashita K, Okuyama M, Mori 
H, Yao M, Kimura A. Molecular basis for 
the recognition of long-chain substrates by 
plant -glucosidases. J Biol Chem. 2013; 
288(26):19296-303.  
_________________________________________________________________________________ 
© 2017 Aswad et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
 
 
 
 
Peer-review history: 
The peer review history for this paper can be accessed here: 
http://sciencedomain.org/review-history/19549 
